Ad is loading...
FRTX
Price
$0.71
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
Earnings call today
SLNO
Price
$51.80
Change
-$2.28 (-4.22%)
Updated
Nov 15 closing price
127 days until earnings call
Ad is loading...

FRTX vs SLNO

Header iconFRTX vs SLNO Comparison
Open Charts FRTX vs SLNOBanner chart's image
Fresh Tracks Therapeutics
Price$0.71
Change-$0.00 (-0.00%)
Volume$540
CapitalizationN/A
Soleno Therapeutics
Price$51.80
Change-$2.28 (-4.22%)
Volume$656.86K
CapitalizationN/A
FRTX vs SLNO Comparison Chart
Loading...
SLNO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
FRTX vs. SLNO commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRTX is a Buy and SLNO is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (FRTX: $0.71 vs. SLNO: $51.80)
Brand notoriety: FRTX and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FRTX: 29% vs. SLNO: 103%
Market capitalization -- FRTX: $4.26M vs. SLNO: $2.23B
FRTX [@Biotechnology] is valued at $4.26M. SLNO’s [@Biotechnology] market capitalization is $2.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FRTX’s FA Score shows that 1 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • FRTX’s FA Score: 1 green, 4 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, SLNO is a better buy in the long-term than FRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLNO’s TA Score shows that 4 TA indicator(s) are bullish.

  • SLNO’s TA Score: 4 bullish, 5 bearish.

Price Growth

FRTX (@Biotechnology) experienced а -3.72% price change this week, while SLNO (@Biotechnology) price change was -9.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

FRTX is expected to report earnings on Nov 18, 2024.

SLNO is expected to report earnings on Mar 25, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($2.23B) has a higher market cap than FRTX($4.26M). SLNO YTD gains are higher at: 28.696 vs. FRTX (-18.951). FRTX has higher annual earnings (EBITDA): -5.65M vs. SLNO (-66.53M). SLNO has more cash in the bank: 266M vs. FRTX (251K). FRTX has less debt than SLNO: FRTX (0) vs SLNO (296K). FRTX has higher revenues than SLNO: FRTX (8.01M) vs SLNO (0).
FRTXSLNOFRTX / SLNO
Capitalization4.26M2.23B0%
EBITDA-5.65M-66.53M8%
Gain YTD-18.95128.696-66%
P/E RatioN/AN/A-
Revenue8.01M0-
Total Cash251K266M0%
Total Debt0296K-
FUNDAMENTALS RATINGS
FRTX vs SLNO: Fundamental Ratings
FRTX
SLNO
OUTLOOK RATING
1..100
5027
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
99
Overvalued
PROFIT vs RISK RATING
1..100
10056
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
7841
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FRTX's Valuation (12) in the null industry is significantly better than the same rating for SLNO (99) in the Medical Specialties industry. This means that FRTX’s stock grew significantly faster than SLNO’s over the last 12 months.

SLNO's Profit vs Risk Rating (56) in the Medical Specialties industry is somewhat better than the same rating for FRTX (100) in the null industry. This means that SLNO’s stock grew somewhat faster than FRTX’s over the last 12 months.

SLNO's SMR Rating (95) in the Medical Specialties industry is in the same range as FRTX (96) in the null industry. This means that SLNO’s stock grew similarly to FRTX’s over the last 12 months.

SLNO's Price Growth Rating (41) in the Medical Specialties industry is somewhat better than the same rating for FRTX (78) in the null industry. This means that SLNO’s stock grew somewhat faster than FRTX’s over the last 12 months.

SLNO's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as FRTX (100) in the null industry. This means that SLNO’s stock grew similarly to FRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SLNO
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
SLNO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BOSYX22.02-0.22
-0.99%
BNY Mellon Sm Cp Val Y
MGGLX34.89-0.41
-1.16%
Morgan Stanley Inst Global Opp L
WFSPX688.63-9.11
-1.31%
iShares S&P 500 Index K
LMTIX25.04-0.38
-1.49%
Franklin U.S. Large Cap Equity I
UOPSX75.14-3.79
-4.80%
ProFunds UltraNASDAQ-100 Svc

FRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FRTX has been loosely correlated with LXRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if FRTX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FRTX
1D Price
Change %
FRTX100%
+0.35%
LXRX - FRTX
42%
Loosely correlated
-8.00%
DRTS - FRTX
38%
Loosely correlated
+1.36%
SLNO - FRTX
37%
Loosely correlated
-4.22%
CALC - FRTX
37%
Loosely correlated
-1.19%
IMVT - FRTX
33%
Poorly correlated
-5.06%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with BRNS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
-4.22%
BRNS - SLNO
56%
Loosely correlated
-29.70%
DAWN - SLNO
40%
Loosely correlated
-7.05%
INZY - SLNO
40%
Loosely correlated
-8.89%
CRNX - SLNO
39%
Loosely correlated
-8.28%
ACLX - SLNO
38%
Loosely correlated
-7.63%
More